GenVec, Inc. Read more here: GenVec reports net loss of $1.9 million for second quarter 2015 [divider] By on August 7, 2015 / Breast Cancer, THINK PINK ROCKS [divider] Previous Post Flowonix Medical's new Patient Therapy Controller approved for market release Next Post Vascular side effects prevent first-line ponatinib use in chronic phase CML [divider]